GIUNCHI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 264
EU - Europa 184
AS - Asia 70
AF - Africa 4
SA - Sud America 3
Totale 525
Nazione #
US - Stati Uniti d'America 261
IT - Italia 63
FR - Francia 42
DE - Germania 25
CN - Cina 17
IN - India 17
IE - Irlanda 13
AE - Emirati Arabi Uniti 11
GB - Regno Unito 10
BG - Bulgaria 8
JP - Giappone 8
HK - Hong Kong 6
UA - Ucraina 6
FI - Finlandia 4
CZ - Repubblica Ceca 3
EG - Egitto 3
NL - Olanda 3
RU - Federazione Russa 3
TW - Taiwan 3
CA - Canada 2
PK - Pakistan 2
PL - Polonia 2
TR - Turchia 2
AR - Argentina 1
BR - Brasile 1
BZ - Belize 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
KR - Corea 1
PE - Perù 1
PH - Filippine 1
SI - Slovenia 1
ZA - Sudafrica 1
Totale 525
Città #
Santa Cruz 30
Ashburn 29
Bologna 15
Dublin 13
Buffalo 10
Mountain View 8
Seattle 8
Sofia 8
Fairfield 7
Southend 7
Chicago 6
Dallas 6
Los Angeles 6
Paris 6
Schaumburg 6
Boardman 5
Bremen 5
Cambridge 5
Houston 5
Bari 4
Helsinki 4
Milan 4
Mumbai 4
Syracuse 4
Wilmington 4
Ann Arbor 3
Bengaluru 3
Chapel Hill 3
Clearwater 3
Columbus 3
Langenhagen 3
Pune 3
Saint Petersburg 3
Tokyo 3
Woodbridge 3
Berlin 2
Bydgoszcz 2
Cairo 2
Cisano Bergamasco 2
Cosenza 2
Council Bluffs 2
Istanbul 2
Las Vegas 2
Montechiarugolo 2
Naples 2
New Delhi 2
New York 2
Phoenix 2
Rimini 2
Saint-Cloud 2
Sant'Ilario d'Enza 2
Taipei 2
Tianjin 2
Amsterdam 1
Anacortes 1
Ancona 1
Andria 1
Arezzo 1
Bangalore 1
Buenos Aires 1
Catanzaro 1
Changsha 1
Chiyoda-ku 1
Cologne 1
Costabissara 1
Crespellano 1
Créteil 1
Davao City 1
Dubai 1
Forlì 1
Frankfurt am Main 1
Grenoble 1
Groningen 1
Guangzhou 1
Hayward 1
Henderson 1
Herndon 1
Hiji 1
Hillsboro 1
Hoffman 1
Hyderabad 1
Jamestown 1
Jerusalem 1
Juliaca 1
Kilburn 1
Kirkland 1
Lahore 1
Lecce 1
Ljubljana 1
Lombard 1
Makishi 1
Milpitas 1
Modena 1
Monmouth Junction 1
Montréal 1
Mount Olive 1
Munger 1
Munich 1
New Taipei 1
Nishi-Tokyo-shi 1
Totale 322
Nome #
The mechanisms of PD-L1 regulation in non-small-cell lung cancer (NSCLC): Which are the involved players?, file e1dcb336-1a59-7715-e053-1705fe0a6cc9 74
Emerging Molecular Technologies in Genitourinary Tumors, file e1dcb335-7579-7715-e053-1705fe0a6cc9 68
Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study, file e1dcb337-8831-7715-e053-1705fe0a6cc9 64
Similarities and differences between clear cell tubulo-papillary and conventional clear cell renal cell carcinoma: A comparative phenotypical and mutational analysis, file e1dcb335-91b9-7715-e053-1705fe0a6cc9 56
Perineural invasion and risk of lethal prostate cancer, file e1dcb338-c8cd-7715-e053-1705fe0a6cc9 47
The Role of [18F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [11C]Choline PET/CT and Histopathological Analysis., file a3399f04-1fc0-4d0c-8e5b-c4230f26120f 35
Renal oncocytosis: a clinicopathological and cytogenetic study of 42 tumours occurring in 11 patients, file e1dcb32d-da0f-7715-e053-1705fe0a6cc9 24
Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes, file df8e4a8a-6b45-4c54-875c-133e0e6d04b4 20
H&E and OCT4/CD34 for the assessment of lympho-vascular invasion in seminoma and embryonal carcinoma, file 7a8900f0-a386-4982-8d49-f9d06e17d55f 19
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC, file 60d6112b-a70b-4dc2-99bd-a748fdad85c5 18
Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer, file 45f255cb-59a8-4c69-a8a4-7a16e806cdc2 17
Effectiveness of Radiomic ZOT Features in the Automated Discrimination of Oncocytoma from Clear Cell Renal Cancer, file 086f3416-1cf1-45b7-948e-221301a79ffb 14
Nodal Occult Metastases in Intermediate- and High-Risk Prostate Cancer Patients Detected Using Serial Section, Immunohistochemistry, and Real-Time Reverse Transcriptase Polymerase Chain Reaction: Prospective Evaluation With Matched-Pair Analysis., file e1dcb32d-e652-7715-e053-1705fe0a6cc9 14
The Role of [18F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [11C]Choline PET/CT and Histopathological Analysis., file da55fa42-14ea-4e1c-99df-b55d2dc07c8f 10
Role of Inter-Observer Variability and Quantification of Muscularis Propria in the Pathological Staging of Bladder Cancer, file e1dcb32d-da0a-7715-e053-1705fe0a6cc9 10
Facing the enigma of the vascular network in hepatocellular carcinomas in cirrhotic and non-cirrhotic livers., file e1dcb32d-ea70-7715-e053-1705fe0a6cc9 10
TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis, file 4f5fda03-28b2-4e48-b969-735143c72b5d 9
The role of MRI in the detection of local recurrence: Added value of multiparametric approach and Signal Intensity/Time Curve analysis, file 9b3c9bac-8209-440f-9974-1c2b22714bf7 9
Multiparametric magnetic resonance imaging for the differential diagnosis between granulomatous prostatitis and prostate cancer: a literature review to an intriguing diagnostic challenge, file 130ad803-4f0c-44eb-b41e-bc9a3505a7cb 3
Transverse prostate maximum sectional area can predict clinically significant prostate cancer in PI-RADS 3 lesions at multiparametric magnetic resonance imaging, file 60f5bd2d-9efb-447f-8348-916887a425e2 3
Cohort profile: the Turin prostate cancer prognostication (TPCP) cohort, file 2f8dddb2-df9e-498c-93e4-fa0034ccec1e 2
FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type, file 5372242a-b8ea-4de8-b654-a76dd4ece0a1 2
PI-RADS version 2.1 for the evaluation of transition zone lesions: a practical guide for radiologists, file e1dcb339-2033-7715-e053-1705fe0a6cc9 2
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC, file 03b199ed-feb0-47f3-883c-ac51c7e13567 1
FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type, file 0963ff0d-96c2-4019-9731-74d23e8ef1fc 1
Comparison of prostate cancer detection rate at targeted biopsy of hub and spoke centers mpMRI: experience matters, file 702aacd8-2f33-40e2-a0d0-1037aaa6cc60 1
TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab, file d8fc375a-5cbb-4198-8fd7-0cf04df35242 1
Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer, file e130cc63-8a46-4532-ae99-d6370e5da019 1
Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challenge, file fb40be83-1f65-4d3f-a0fa-1f0426b905be 1
Totale 536
Categoria #
all - tutte 2.211
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.211


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 0 1 0 3
2020/202150 3 1 1 2 0 4 2 4 6 5 13 9
2021/2022116 5 2 3 6 9 2 6 8 8 5 43 19
2022/2023174 13 16 35 27 12 10 4 9 13 8 23 4
2023/2024192 8 8 5 23 15 45 31 19 22 13 3 0
Totale 536